Global Advisory Committee on Vaccine Safety, 6-7 June 2006.
D000276:Adjuvants, Immunologic / Q000009:adverse effects; D000328:Adult; D019433:Chickenpox Vaccine / Q000009:adverse effects; D016903:Drug Monitoring; D005260:Female; D006801:Humans; D007223:Infant; D007252:Influenza Vaccines / Q000009:adverse effects; D011247:Pregnancy; D011358:Product Surveillance, Postmarketing; D022243:Rotavirus Vaccines / Q000009:adverse effects; D013185:Squalene / Q000009:adverse effects; D014612:Vaccines / Q000009:adverse effects*; D014944:World Health Organization / Q000458:organization & administration
D000276:Adjuvants, Immunologic; D019433:Chickenpox Vaccine; D007252:Influenza Vaccines; D022243:Rotavirus Vaccines; D014612:Vaccines; D013185:Squalene